The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAscential Regulatory News (ASCL)

Share Price Information for Ascential (ASCL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 312.20
Bid: 0.00
Ask: 377.00
Change: 0.00 (0.00%)
Spread: 65.20 (20.911%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 312.20
ASCL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

28 Mar 2024 11:33

RNS Number : 7308I
Ascential PLC
28 March 2024

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BYM8GJ06

Issuer Name

ASCENTIAL PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights; An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

T. Rowe Price Associates, Inc.

City of registered office (if applicable)

Baltimore

Country of registered office (if applicable)

United States

4. Details of the shareholder

Name

City of registered office

Country of registered office

T. Rowe Price International Ltd

London

United Kingdom

5. Date on which the threshold was crossed or reached

26-Mar-2024

6. Date on which Issuer notified

27-Mar-2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

4.966540

4.021135

8.987675

40050294

Position of previous notification (if applicable)

5.07

0.00

5.07

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BYM8GJ06

0

22131573

0.000000

4.966540

Sub Total 8.A

22131573

4.966540%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Shares on loan

N/A

17918721

4.021135

Sub Total 8.B1

17918721

4.021135%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

T. Rowe Price Associates, Inc.

T. Rowe Price International Ltd

8.987675%

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

12. Date of Completion

27-Mar-2024

13. Place Of Completion

Baltimore, Maryland, USA

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
HOLFLFVLVIITFIS
Date   Source Headline
2nd Mar 20219:52 amRNSExternal Directorship
2nd Mar 20219:42 amRNSTotal Voting Rights
1st Mar 202110:01 amRNSNotice of Results
17th Feb 20216:23 pmRNSHolding(s) in Company
12th Feb 20217:00 amRNSDeHavilland sale concludes £257.9m BEP disposal
28th Jan 20215:30 pmRNSHolding(s) in Company
20th Jan 20218:25 amRNSSale of Groundsure for £170m
5th Jan 20213:22 pmRNSBlock listing Interim Review
5th Jan 20213:06 pmRNSTotal Voting Rights
5th Jan 20217:00 amRNSAppointment of Non-Executive Directors
16th Dec 20207:00 amRNSAcquisition of Digital Commerce businesses
15th Dec 20204:34 pmRNSHolding(s) in Company
15th Dec 20207:00 amRNSSale of Glenigan for £72.9m
10th Dec 20207:00 amRNSTrading update and segmental restatement
26th Nov 20202:07 pmRNSHolding(s) in Company
16th Nov 202011:42 amRNSHolding(s) in Company
5th Nov 202012:01 pmRNSHolding(s) in Company
22nd Oct 20204:25 pmRNSHolding(s) in Company
7th Oct 20201:02 pmRNSHolding(s) in Company
2nd Oct 20201:37 pmRNSDirector/PDMR Shareholding
1st Oct 20204:53 pmRNSTotal Voting Rights
29th Sep 20207:00 amRNSCOO Appointment
18th Aug 20201:21 pmRNSHolding(s) in Company
12th Aug 20204:33 pmRNSDirector/PDMR Shareholding
4th Aug 20207:00 amRNSMoney20/20 US and Europe 2020 cancellations
31st Jul 202012:10 pmRNSExternal Directorship
27th Jul 20207:05 amRNSAppointment of Non-Executive Director
27th Jul 20207:00 amRNSHalf-year Report
21st Jul 20204:14 pmRNSNotice of Interim Results date
6th Jul 202012:00 pmRNSHolding(s) in Company
6th Jul 202011:59 amRNSHolding(s) in Company
11th Jun 20204:00 pmRNSDirector Declaration
2nd Jun 202011:14 amRNSTotal Voting Rights
18th May 202010:06 amRNSDirector/PDMR Shareholding
7th May 20202:44 pmRNSDirector/PDMR Shareholding
6th May 20201:35 pmRNSResult of AGM
1st May 202011:33 amRNSTotal Voting Rights
29th Apr 20207:00 amRNSCovenant amendments and Q1 trading update
21st Apr 20205:02 pmRNSHolding(s) in Company
20th Apr 20204:38 pmRNSUpdate on 2020 AGM
16th Apr 20205:02 pmRNSHolding(s) in Company
3rd Apr 20202:30 pmRNSHolding(s) in Company
3rd Apr 20207:00 amRNSCannes Lions Cancellation & Other Actions
2nd Apr 20201:00 pmRNSEdge by Ascential launches Market Share 2.0
1st Apr 20205:23 pmRNSTotal Voting Rights
24th Mar 20202:00 pmRNSMoney20/20 Europe deferral to September 2020
18th Mar 20201:00 pmRNSCannes Lions deferral to contingency dates
17th Mar 20207:00 amRNSTransaction in Own Shares
16th Mar 20207:00 amRNSTransaction in Own Shares
13th Mar 20209:37 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.